Wilate, 500 IU VWF/500 IU FVIII, powder and solvent for solution for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

wilate, 500 iu vwf/500 iu fviii, powder and solvent for solution for injection

octapharma (ip) sprl - human factor viii; von willebrand factor human - powder and solvent for solution for injection - 500/500 international unit(s) - blood coagulation factors; von willebrand factor and coagulation factor viii in combination

Wilate, 1000 IU VWF/1000 IU FVIII, powder and solvent for solution for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

wilate, 1000 iu vwf/1000 iu fviii, powder and solvent for solution for injection

octapharma (ip) sprl - human factor viii; von willebrand factor human - powder and solvent for solution for injection - 1000/1000 international unit(s) - blood coagulation factors; von willebrand factor and coagulation factor viii in combination

CSL Bulk Human Coagulation Factor VIII 1000 IU / von Willebrand factor 2400 IU powder for injection vial Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

csl bulk human coagulation factor viii 1000 iu / von willebrand factor 2400 iu powder for injection vial

csl behring australia pty ltd - von willebrand factor, quantity: 2400 iu; factor viii, quantity: 1000 iu - injection, powder for - excipient ingredients: sodium chloride; sodium citrate dihydrate; calcium chloride dihydrate; albumin; sucrose; trometamol - von willebrand disease (vwd) - treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with vwd, when desmopressin (ddavp) treatment alone is ineffective or contraindicated. haemophilia a (congenital fviii deficiency) - prophylaxis and treatment of bleeding in patients with haemophilia a.

CSL Bulk Human Coagulation Factor VIII 500 IU (100 IU/mL) / von Willebrand factor 1200 IU powder for injection vial Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

csl bulk human coagulation factor viii 500 iu (100 iu/ml) / von willebrand factor 1200 iu powder for injection vial

csl behring australia pty ltd - von willebrand factor, quantity: 1200 iu; factor viii, quantity: 500 iu - injection, powder for - excipient ingredients: sucrose; trometamol; sodium chloride; albumin; sodium citrate dihydrate; calcium chloride dihydrate - von willebrand disease (vwd) - treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with vwd, when desmopressin (ddavp) treatment alone is ineffective or contraindicated. haemophilia a (congenital fviii deficiency) - prophylaxis and treatment of bleeding in patients with haemophilia a.

CSL Bulk Human Coagulation Factor VIII 500 IU (50 IU/mL) / von Willebrand factor 1200 IU powder for injection vial Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

csl bulk human coagulation factor viii 500 iu (50 iu/ml) / von willebrand factor 1200 iu powder for injection vial

csl behring australia pty ltd - von willebrand factor, quantity: 1200 iu; factor viii, quantity: 500 iu - injection, powder for - excipient ingredients: sodium citrate dihydrate; trometamol; calcium chloride dihydrate; albumin; sucrose; sodium chloride - von willebrand disease (vwd) - treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with vwd, when desmopressin (ddavp) treatment alone is ineffective or contraindicated. haemophilia a (congenital fviii deficiency) - prophylaxis and treatment of bleeding in patients with haemophilia a.

CSL Bulk Human Coagulation Factor VIII 250 IU / von Willebrand factor 600 IU powder for injection vial Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

csl bulk human coagulation factor viii 250 iu / von willebrand factor 600 iu powder for injection vial

csl behring australia pty ltd - von willebrand factor, quantity: 600 iu; factor viii, quantity: 250 iu - injection, powder for - excipient ingredients: calcium chloride dihydrate; sodium chloride; trometamol; sucrose; albumin; sodium citrate dihydrate - von willebrand disease (vwd) - treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with vwd, when desmopressin (ddavp) treatment alone is ineffective or contraindicated. haemophilia a (congenital fviii deficiency) - prophylaxis and treatment of bleeding in patients with haemophilia a.

Haemate P 600 IU vWF/250 IU FVIII 600 IU - 250 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

haemate p 600 iu vwf/250 iu fviii 600 iu - 250 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - human coagulation factor viii 250 iu; human factor von willebrand 600 iu - powder and solvent for solution for injection/infusion - 600 iu - 250 iu - human coagulation factor viii 250 iu; factor von willebrand 600 iu - von willebrand factor and coagulation factor viii in combination

HAEMATE P 1000 IU FVIII 2400 IU VWF İsrail - İngilizce - Ministry of Health

haemate p 1000 iu fviii 2400 iu vwf

csl behring ltd., israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection/infusion - factor viii (human) 1000 iu / 15 ml; von willebrand factor 2400 iu / 15 ml - coagulation factor viii - coagulation factor viii - congenital and acquired deficiency of blood clotting factor viii: severe or moderate haemophilia,prophylaxis during operation, von willebrands disease.

HAEMATE P 500 IU FVIII 1200 IU VWF İsrail - İngilizce - Ministry of Health

haemate p 500 iu fviii 1200 iu vwf

csl behring ltd., israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection/infusion - factor viii (human) 500 iu / 10 ml; von willebrand factor 1200 iu / 10 ml - coagulation factor xiii - coagulation factor xiii - congenital and acquired deficiency of blood clotting factor viii: severe or moderate haemophilia, prophylaxis during operation, von willebrands disease.

HAEMATE P 250 IU FVIII 600 IU VWF İsrail - İngilizce - Ministry of Health

haemate p 250 iu fviii 600 iu vwf

csl behring ltd., israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection/infusion - factor viii (human) 250 iu / 5 ml; von willebrand factor 600 iu / 5 ml - coagulation factor viii - coagulation factor viii - congenital and acquired deficiency of blood clotting factor viii: severe or moderate haemophilia, prophylaxis during operation, von willebrand's disease.